Sanofi Detailed Consensus >> Business P&L
Last Update: 2020-07-24

Please note: The P&L and the divisions show the restated Q2 2019 and FY 2019 numbers, including the sale of the equity investment in Regeneron.


KPI[EUR m]Q2 2019FY 2019Q2 2020 EFY 2020 EFY 2021 EFY 2022 EFY 2023 EFY 2024 E
Net salesNumber of Estimates121616161616
Net salesHighest8,45537,89540,37543,05945,72148,969
Net salesConsensus (Mean)8,62836,1268,26636,81638,68640,62041,58043,081
Net salesLowest7,98036,15337,22238,75839,47539,810
Other revenuesNumber of Estimates121616161616
Other revenuesHighest4031,6131,6911,7541,8361,960
Other revenuesConsensus (Mean)3521,5053411,5071,5631,6051,6461,692
Other revenuesLowest2611,2861,3071,3461,3831,440
Cost of salesNumber of Estimates121616161616
Cost of salesHighest-2,516-11,635-11,581-11,735-11,824-11,914
Cost of salesConsensus (Mean)-2,767-11,973-2,635-12,106-12,477-12,868-13,122-13,467
Cost of salesLowest-2,730-12,536-13,228-13,879-14,494-15,275
Gross ProfitNumber of Estimates121616161616
Gross ProfitHighest6,12026,85628,89230,93533,06335,601
Gross ProfitConsensus (Mean)6,21325,6585,97226,21727,77329,35830,10531,307
Gross ProfitLowest5,66725,63626,78428,10928,70329,156
- as % of net sales (gross margin)Number of Estimates121616161616
- as % of net sales (gross margin)Highest74.072.773.373.973.974.1
- as % of net sales (gross margin)Consensus (Mean)72.071.072.271.271.872.372.472.7
- as % of net sales (gross margin)Lowest71.070.671.171.471.271.0
R&D expensesNumber of Estimates121616161616
R&D expensesHighest-1,403-5,746-5,785-5,869-5,688-5,442
R&D expensesConsensus (Mean)-1,587-6,018-1,478-5,962-6,032-6,065-6,068-6,108
R&D expensesLowest-1,565-6,155-6,220-6,305-6,370-6,555
SG&A expensesNumber of Estimates121616161616
SG&A expensesHighest-2,200-9,370-9,195-9,048-9,011-8,958
SG&A expensesConsensus (Mean)-2,459-9,883-2,300-9,660-9,707-9,722-9,758-9,851
SG&A expensesLowest-2,415-9,926-9,925-10,397-10,799-11,245
Other current operating income/expenseNumber of Estimates121616161616
Other current operating income/expenseHighest-79-495-795-1,091-1,377-1,630
Other current operating income/expenseConsensus (Mean)-91-382-201-883-1,307-1,751-2,146-2,490
Other current operating income/expenseLowest-284-1,214-1,722-2,322-2,776-3,152
Share of profit/loss of associatesNumber of Estimates121313131313
Share of profit/loss of associatesHighest20131136141143146
Share of profit/loss of associatesConsensus (Mean)7943018181919
Share of profit/loss of associatesLowest-21-5-5-5-5
Net income attributable to non-controlling interestsNumber of Estimates121313131313
Net income attributable to non-controlling interestsHighest-5-29-28-27-25-23
Net income attributable to non-controlling interestsConsensus (Mean)-5-35-8-37-36-35-35-35
Net income attributable to non-controlling interestsLowest-13-50-45-45-45-45
Business operating incomeNumber of Estimates121313131313
Business operating incomeHighest2,15710,00411,20212,49612,76914,292
Business operating incomeConsensus (Mean)2,0789,3491,9909,67810,61011,71711,92112,569
Business operating incomeLowest1,8289,46310,25410,96710,70110,639
- as % of net sales (operating margin)Number of Estimates121313131313
- as % of net sales (operating margin)Highest26.227.328.830.130.732.4
- as % of net sales (operating margin)Consensus (Mean)24.125.924.126.427.629.028.929.5
- as % of net sales (operating margin)Lowest22.225.826.828.127.126.7
Financial income & expenseNumber of Estimates121616161616
Financial income & expenseHighest-55-222-157-110-4626
Financial income & expenseConsensus (Mean)-96-303-79-297-263-232-195-153
Financial income & expenseLowest-100-376-356-375-376-397
- % tax rateNumber of Estimates121616161616
- % tax rateHighest-21.3-20.9-21.0-20.5-20.5-20.3
- % tax rateConsensus (Mean)-22.0-22.0-21.9-21.9-21.9-21.8-21.8-21.8
- % tax rateLowest-22.1-22.0-22.0-22.0-22.1-22.1
Business net incomeNumber of Estimates121313131313
Business net incomeHighest1,6147,6548,4529,4479,90911,356
Business net incomeConsensus (Mean)1,5467,0501,4927,3268,0848,9809,1729,715
Business net incomeLowest1,3647,1627,7688,3338,2248,187
- as % of net sales (net profit margin)Number of Estimates121313131313
- as % of net sales (net profit margin)Highest19.520.721.723.424.125.8
- as % of net sales (net profit margin)Consensus (Mean)17.919.518.020.021.022.322.322.8
- as % of net sales (net profit margin)Lowest16.819.620.421.520.820.6
Number of sharesNumber of Estimates121313131313
Number of sharesHighest1,2521,2531,2561,2561,2571,259
Number of sharesConsensus (Mean)1,2491,2501,2521,2511,2491,2481,2471,246
Number of sharesLowest1,2501,2461,2411,2371,2331,230
Business EPS (in EUR)Number of Estimates121313131313
Business EPS (in EUR)Highest1.296.116.807.628.049.03
Business EPS (in EUR)Consensus (Mean)1.245.641.195.866.477.207.367.80
Business EPS (in EUR)Lowest1.095.726.216.676.566.53
Dividend Per Share (in EUR)Number of Estimates-1212121212
Dividend Per Share (in EUR)Highest-3.313.634.074.354.79
Dividend Per Share (in EUR)Consensus (Mean)-3.15-3.223.403.683.854.08
Dividend Per Share (in EUR)Lowest-3.093.143.343.413.48
Disclaimer

This document has been issued by Vara Research GmbH for information purposes only and is not intended to constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings and business developments of the relevant company. The company did not participate in the compilation of the estimates and it does not endorse them. Such estimates and forecasts cannot be independently verified by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not responsible or liable as to its accuracy and completeness.